Cost-effectiveness of the anti-vascular endothelial growth factor intravitreal injection and panretinal photocoagulation for patients with proliferative diabetic retinopathy in South Korea.
Hyeon Jeong LeeSonghee ChoJungeun ParkYan JinHyung Min KimDonghyun JeePublished in: BMC health services research (2023)
In our study, the anti-VEGF injection for PDR was cost-effective from the payer and societal perspectives.